PROF Profound Medical Corp

USD 8.28 0.13 1.595092
Icon

Profound Medical Corp (PROF) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 8.28

+0.13 (+1.60)%

USD 0.21B

0.03M

USD 10.89(+31.49%)

N/A

Icon

PROF

Profound Medical Corp (USD)
COMMON STOCK | NSD
USD 8.28
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.21B

N/A

USD 8.28

Profound Medical Corp (PROF) Stock Forecast

Show ratings and price targets of :
USD 10.89
(+31.49%)

Based on the Profound Medical Corp stock forecast from 2 analysts, the average analyst target price for Profound Medical Corp is USD 10.89 over the next 12 months. Profound Medical Corp’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Profound Medical Corp is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Profound Medical Corp’s stock price was USD 8.28. Profound Medical Corp’s stock price has changed by -1.08% over the past week, -0.48% over the past month and -9.41% over the last year.

No recent analyst target price found for Profound Medical Corp
No recent average analyst rating found for Profound Medical Corp

Company Overview Profound Medical Corp

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead ...Read More

2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5

131

December

USD

USA

Adjusted Closing Price for Profound Medical Corp (PROF)

Loading...

Unadjusted Closing Price for Profound Medical Corp (PROF)

Loading...

Share Trading Volume for Profound Medical Corp Shares

Loading...

Compare Performance of Profound Medical Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PROF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Profound Medical Corp (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DXCM
DexCom Inc -0.45 (-0.32%) USD51.34B 103.24 55.96

ETFs Containing PROF

Symbol Name PROF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Profound Medical Corp (PROF) Stock

Based on ratings from 2 analysts Profound Medical Corp's stock is Buy . Stock Target Advisor's fundamental analysis is Bearish. The stock has 2 buy, sell and 2 hold ratings.

Unfortunately we do not have enough data on PROF's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for PROF is USD 10.89 over the next 12 months. The maximum analyst target price is USD 12.75 while the minimum anlayst target price is USD 9.

PROF stock's Price/Earning ratio is 73.68. Our analysis grades PROF stock's Price / Earning ratio at F. This means that PROF stock's Price/Earning ratio is above 75% of the stocks in the Medical Devices sector in the NSD exchange. Based on this PROF may be a overvalued for its sector.

The last closing price of PROF's stock was USD 8.28.

The most recent market capitalization for PROF is USD 0.21B.

Based on targets from 2 analysts, the average taret price for PROF is projected at USD 10.89 over the next 12 months. This means that PROF's stock price may go up by +31.49% over the next 12 months.

We can't find any ETFs which contains Profound Medical Corp's stock.

As per our most recent records Profound Medical Corp has 131 Employees.

Profound Medical Corp's registered address is 2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5. You can get more information about it from Profound Medical Corp's website at https://www.profoundmedical.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...